Dean E Miller

Bio

Dean joined Novitas Capital in 1998, and is focused on Life Sciences investments. He has over 18 years of experience working for and with both large and small companies. Dean is currently on the Board of Directors of Cellumen and VIPdesk, and is an observer to the Board of Directors of Agile Therapeutics, GelMed Sciences, Logical Therapeutics, and Neuronyx. He has led investments in and served as director or observer of Renal Solutions (acquired by Fresenius (NYSE: FMS)), Incurrent Solutions (acquired by Online Resources (NASDAQ: ORCC)) and LearnNow, Inc. (acquired by Edison Schools). Previously, Dean served as the Chief Financial Officer of Adaptiv Learning Systems, a venture-backed start-up company that was spun out of the University of Pennsylvania’s Department of Psychology. Adaptiv Learning Systems provides resiliency training to corporations, educational institutions and a variety of other clients. At Adaptiv, he worked with the other Senior Management team members to analyze and execute financial, strategic, operational and marketing decisions. Dean began his career at the Chubb Group of Insurance Companies, where he held a variety of management positions. While at Chubb, Dean was responsible for operations, financial management, technology management and internal consulting. In his last position at Chubb, he managed a regional department of 120 people with responsibility for over $250 million in revenue.